Advanced NMN: Slc12a8 Transporter Technology

NMN with Slc12a8 transporter delivers NAD+ in 30 minutes vs 6-8 hours for NR. No NAM buildup. Enteric capsules outperform liposomal. Choose 250mg, 500mg, or 1000mg.

30 Minutes

Cellular Absorption via Slc12a8

30 min
Absorption
Slc12a8
Transporter
Enteric
Capsules
Zero
NAM Buildup

Understanding Advanced NMN and Slc12a8 Transporter Technology

NMN (Nicotinamide Mononucleotide, Wikidata Q27125809) is a direct precursor to NAD+ (Wikidata Q71535049), the essential coenzyme required for cellular energy production, DNA repair, and sirtuin activation. NAD+ levels decline approximately 50% between ages 40 and 60, contributing to reduced mitochondrial function, impaired DNA repair, and accelerated aging. Advanced NMN supplementation addresses this decline through a revolutionary delivery mechanism.

The Slc12a8 Transporter: A Game-Changing Discovery

Slc12a8 is a specialized transporter protein located primarily in the small intestine that enables direct cellular uptake of NMN molecules. This transporter was identified in 2019 research and explains why NMN achieves therapeutic cellular concentrations within approximately 30 minutes of oral administration. NR (Nicotinamide Riboside) cannot use this transporter and must undergo multiple enzymatic conversion steps requiring 6-8 hours. This fundamental difference in absorption makes NMN the superior choice for NAD+ restoration.

RevGenetics Advanced NMN formulations are designed to maximize Slc12a8-mediated uptake. By using enteric-coated capsules that protect NMN through stomach acid and release it directly in the small intestine where Slc12a8 transporters are concentrated, we ensure optimal absorption efficiency. This targeted delivery system achieves rapid cellular NAD+ restoration impossible with other delivery methods.

The NAM Accumulation Problem with NR

When NR (Nicotinamide Riboside) converts to NAD+, it produces NAM (Nicotinamide) as a byproduct. NAM accumulation temporarily inhibits sirtuin enzymes, the very longevity-promoting proteins that NAD+ supplements are supposed to support. This creates a counterproductive cycle where the supplement undermines its own benefits. NMN via Slc12a8 transport converts directly to NAD+ without producing NAM, eliminating this problem entirely and allowing sirtuins to function optimally.

Why Enteric Capsules Outperform Liposomal NMN

Liposomal NMN has multiple problems that compromise effectiveness: water-based liposomal cores cause NMN degradation within 3-6 months, liposomes bypass Slc12a8 detection leading to slow 8-hour metabolism or complete excretion, and strong liposomes resist breakdown (a 2024 study of 18 brands showed sonication failed to release contents). Enteric capsules protect NMN through stomach acid and release it precisely where Slc12a8 transporters can absorb it, achieving superior bioavailability without stability concerns.

Anthony Loera, Founder and CEO of RevGenetics

Anthony Loera, Founder & CEO

19+ years formulating longevity supplements | Pioneer in NMN delivery technology

Last Updated: January 7, 2026

NMN vs NR vs Traditional NAD+ Precursors

Why Slc12a8-delivered NMN is superior

Feature NMN (Slc12a8) NR (Riboside) Traditional Precursors
Absorption Time ~30 minutes 6-8 hours Variable, often slow
Conversion to NAD+ Direct one-step Multiple enzymatic steps Multiple steps
NAM Accumulation None Significant Variable
Sirtuin Interference None May inhibit Potential
Transport Mechanism Slc12a8 direct Conversion-dependent Highly variable
Bioavailability Superior Limited by conversion Generally poor
Clinical Evidence GRAS since 2018 Established Limited

Enteric Capsules vs Liposomal NMN

Why delivery method matters for NMN effectiveness

Factor Enteric Capsules Liposomal
Slc12a8 Compatibility ✓ Optimal ✗ Bypasses transporter
Absorption Time 30 minutes 8 hours or excretion
Stability 24+ months 3-6 months (degradation)
Content Release ✓ Complete ✗ Often fails (2024 study)
Water Exposure Protected Water core degrades NMN

Shop Advanced NMN

MAXIMUM POTENCY Advanced NMN 1000mg with Slc12a8 transporter technology

Advanced NMN 1000

  • 1000mg NMN per serving
  • Slc12a8 transporter technology
  • 30-minute absorption
  • Enteric capsule delivery
  • Zero NAM buildup
  • Maximum NAD+ restoration
View NMN 1000
DAILY MAINTENANCE Advanced NMN 500mg enteric capsules

Advanced NMN 50

  • 50mg NMN per capsule
  • Slc12a8 transporter compatible
  • 30-minute absorption
  • Enteric capsule protection
  • Balanced daily dosing
  • Third-party tested
View Advanced NMN 50
FLEXIBLE DOSING Pure NMN Powder for custom dosing

NMN Powder

  • Pure NMN powder
  • Custom dosing flexibility
  • Slc12a8 compatible
  • Cost-effective option
  • Third-party tested purity
  • Pharmaceutical grade
View NMN Powder

Frequently Asked Questions

What is Slc12a8 transporter technology?

Slc12a8 is a specialized transporter protein in the small intestine enabling direct cellular uptake of NMN within 30 minutes. NR cannot use this transporter and requires 6-8 hours for multiple enzymatic conversion steps. This makes NMN the superior choice for rapid NAD+ restoration.

Why is NMN better than NR?

NMN is superior for three reasons: (1) 30-minute absorption via Slc12a8 vs 6-8 hours for NR, (2) direct one-step conversion to NAD+ vs multiple steps, and (3) no NAM accumulation. NR produces NAM that inhibits sirtuins, counteracting its own benefits.

Why are enteric capsules better than liposomal?

Enteric capsules protect NMN and release it where Slc12a8 transporters absorb it. Liposomal NMN degrades in 3-6 months from water-based cores, bypasses Slc12a8 detection, and often fails to release contents (2024 study of 18 brands showed sonication could not release contents).

What is the NAM accumulation problem?

When NR converts to NAD+, it produces NAM (Nicotinamide) byproduct. NAM temporarily inhibits sirtuin enzymes, the longevity proteins NAD+ supplements support. This counterproductive cycle undermines benefits. NMN via Slc12a8 bypasses NAM production entirely.

What NMN dosage should I take?

250-500mg daily for maintenance and general support. 500-1000mg daily for enhanced therapeutic benefits or significant age-related decline. Clinical studies show doses up to 900mg increase blood NAD+ with superior results at higher doses. Start lower and increase based on response.

Is NMN safe for long-term use?

Yes. NMN has GRAS status since 2018 and is considered a food ingredient. A 2024 study (Takahashi et al.) followed 500mg daily for 52 weeks with no safety concerns and sustained benefits. NMN occurs naturally in broccoli, avocado, and tomatoes.

Important Health Information

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Consult healthcare providers before starting NMN supplementation, especially if taking medications.

Quality Assurance:

  • GRAS status since 2018
  • Third-party tested for purity
  • Enteric capsule delivery
  • Pharmaceutical-grade NMN
  • 24-month stability tested
  • Ships to 50+ countries